Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natasha Harper

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Archives of Disease in Childhood|November 5, 2014
The root cause of a blistering eruptionNatasha Harper, Stephen Orpin, Anisha Mehta
Acta Dermato-Venereologica|January 26, 2017
Cost-effectiveness in Psychodermatology: A Case SeriesJonathan M R Goulding, Natasha Harper, Liam Kennedy, et al.
Journal of Neurological Surgery. Part B, Skull Base|November 8, 2021
Extended Scalp Flaps for Extensive Soft Tissue Scalp Defects as a Day Surgery Procedure Under Local Anesthetic: A Single Centre ExperienceMarco Malahias, Edward Ackling, Omer Zubair, et al.
Clinical and Experimental Dermatology|March 27, 2023
Are existing validated severity scores for epidermolysis bullosa reflective of the burden of disease in patients with epidermolysis bullosa simplex?Manrup K Hunjan, Ajoy Bardhan, Louise Zuzarte, et al.
Clinical and Experimental Dermatology|May 16, 2023
IgA nephropathy in adults with epidermolysis bullosaManrup K Hunjan, Ajoy Bardhan, Natasha Harper, et al.
Clinical and Experimental Dermatology|April 15, 2022
Successful use of rituximab, an anti-CD20 monoclonal antibody, to treat IgA nephropathy in a patient with recessive dystrophic epidermolysis bullosaManrup Kaur Hunjan, Ajoy Bardhan, Natasha Harper, et al.
Journal of the American Podiatric Medical Association|December 10, 2020
A Retrospective Review of Clinical Problems and Interventions in Patients Attending Epidermolysis Bullosa Podiatry Clinics Highlighting the Demand and Need for Specialized ServicesJemima E Mellerio, Manpreet K Lakhan, Sevgi E Kozakli, et al.
The Journal of Investigative Dermatology|December 29, 2023
Genotype-Phenotype Correlation in Junctional Epidermolysis Bullosa: Signposts to SeverityDavid Wen, Manrup Hunjan, Ajoy Bardhan, et al.
The Journal of Investigative Dermatology|February 19, 2025
Enamel Phenotype in Junctional Epidermolysis BullosaDavid Wen, Manrup Hunjan, Ajoy Bardhan, et al.
The British Journal of Dermatology|December 20, 2021
The epidemiology of epidermolysis bullosa in England and Wales: data from the national epidermolysis bullosa databaseGabriela Petrof, Maria Papanikolaou, Anna E Martinez, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Archives of Disease in Childhood|November 5, 2014
The root cause of a blistering eruptionNatasha Harper, Stephen Orpin, Anisha Mehta
Acta Dermato-Venereologica|January 26, 2017
Cost-effectiveness in Psychodermatology: A Case SeriesJonathan M R Goulding, Natasha Harper, Liam Kennedy, et al.
Journal of Neurological Surgery. Part B, Skull Base|November 8, 2021
Extended Scalp Flaps for Extensive Soft Tissue Scalp Defects as a Day Surgery Procedure Under Local Anesthetic: A Single Centre ExperienceMarco Malahias, Edward Ackling, Omer Zubair, et al.
Clinical and Experimental Dermatology|March 27, 2023
Are existing validated severity scores for epidermolysis bullosa reflective of the burden of disease in patients with epidermolysis bullosa simplex?Manrup K Hunjan, Ajoy Bardhan, Louise Zuzarte, et al.
Clinical and Experimental Dermatology|May 16, 2023
IgA nephropathy in adults with epidermolysis bullosaManrup K Hunjan, Ajoy Bardhan, Natasha Harper, et al.
Clinical and Experimental Dermatology|April 15, 2022
Successful use of rituximab, an anti-CD20 monoclonal antibody, to treat IgA nephropathy in a patient with recessive dystrophic epidermolysis bullosaManrup Kaur Hunjan, Ajoy Bardhan, Natasha Harper, et al.
Journal of the American Podiatric Medical Association|December 10, 2020
A Retrospective Review of Clinical Problems and Interventions in Patients Attending Epidermolysis Bullosa Podiatry Clinics Highlighting the Demand and Need for Specialized ServicesJemima E Mellerio, Manpreet K Lakhan, Sevgi E Kozakli, et al.
The Journal of Investigative Dermatology|December 29, 2023
Genotype-Phenotype Correlation in Junctional Epidermolysis Bullosa: Signposts to SeverityDavid Wen, Manrup Hunjan, Ajoy Bardhan, et al.
The Journal of Investigative Dermatology|February 19, 2025
Enamel Phenotype in Junctional Epidermolysis BullosaDavid Wen, Manrup Hunjan, Ajoy Bardhan, et al.
The British Journal of Dermatology|December 20, 2021
The epidemiology of epidermolysis bullosa in England and Wales: data from the national epidermolysis bullosa databaseGabriela Petrof, Maria Papanikolaou, Anna E Martinez, et al.
Pageof 2